Cite
MLA Citation
William D Tap et al.. “Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial.” Lancet, vol. 394, no. 10197, 2019, pp. 478–487. http://access.bl.uk/ark:/81055/vdc_100089543188.0x000053